^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
OncoKey™ SL 60 Plus Assay

Company:
Luye Group
Type:
Laboratory Developed Test
Related tests:

Details

Evidence
The Oncokey SL 60 Plus Auto is a Next-Generation sequencing (NGS)-based Research Use Only (RUO) test intended for the detection of single nucleotide variations (SNVs), insertions/deletions (INDELs), copy number variations (CNVs), microsatellite instability (MSI), oncogenic pathogens and fusion genes in 60 Plus targeted genes, in Formalin Fixed Paraffin Embedded (FFPE) Tissue specimens.
Cancer:
Bladder Cancer, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Skin Cancer
Gene:
AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), BRAF (B-raf proto-oncogene), BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset), CDKN2A (Cyclin Dependent Kinase Inhibitor 2A)
See More ...
Method:
Next-Generation Sequencing (NGS)